CAS: 906669-07-6 - 3H-1,2,4-Triazol-3-one,5-(2,4-dihydroxyphenyl)-2,4-dihydro-4-(4-methylphenyl)-
Fórmula:C15H13N3O3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | KPLH1130 REF: TM-T11765CAS: 906669-07-6 | 99.07% | 82,00 €~2.270,00 € | Jue 05 Dic 24 |
 | KPLH1130 REF: 3D-GLB66907CAS: 906669-07-6 | Min. 95% | A consultar | Jue 16 Ene 25 |
KPLH1130
CAS:906669-07-6
KPLH1130, a PDK inhibitor, boosts glucose tolerance and reduces inflammation in high-fat diet mice.
Fórmula:
C15H13N3O3
Pureza:
99.07%
Forma y color:
Solid
Peso molecular:
283.28
Ref: TM-T11765
| 1mg | 82,00 € | ||
| 5mg | 212,00 € | ||
| 10mg | 343,00 € | ||
| 25mg | 578,00 € | ||
| 50mg | 827,00 € | ||
| 100mg | 1.105,00 € | ||
| 500mg | 2.270,00 € | ||
| 1mL*10mM (DMSO) | 187,00 € |
Entrega estimada en Estados Unidos, el Jueves 5 de Diciembre de 2024
KPLH1130
CAS:906669-07-6
KPLH1130 is an analog of a protein kinase inhibitor that has shown promising results as …
Fórmula:
C15H13N3O3
Pureza:
Min. 95%
Peso molecular:
283.28 g/mol
Ref: 3D-GLB66907
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 16 de Enero de 2025
